New York, NJ, June 28, 2018 --(PR.com
)-- A brief overview from Q&A session with:
· Fabrice Schlegel - Senior Engineer at Amgen
· Mohamed AbouGhaly - Postdoctoral Researcher at Purdue University
· Timothy McCoy, Associate Director, Pharmaceutical Development Biologics at Sanofi
*****What do you see as the greatest challenge to overcome in the field at the moment?*****
Fabrice Schlegel: Lack of resources invested by biotech companies in the development of more innovative processes for lyophilization.
Mohamed AbouGhaly: The greatest challenge is in turning process from a trial and error approach to a more systematic and predictable approach.
Timothy McCoy: Scalability is always a challenge; especially with the freezing step. There are currently techniques out there to better control the ice nucleation process, and to allow better control of primary and secondary drying.
What technology has really caught your eye in the Lyophilization field in the past year?
Fabrice Schlegel: "The move from in-vivo to in-silico experiments to reduce the experimental burden related to lyophilization process development."
Mohamed AbouGhaly: The continuous advances in wireless temperature probes that can monitor products in process.
Timothy McCoy: "I am not sure if there have been many new technological innovations over the last year, that are completely new to the field. However, many technologies have been improved and expanded. I am interested in the mini lyophilizer systems such as microFD and LyoCapsule; PAT technologies such as LyoDEA."
Full transcripts are available on the Download Centre of lyophilization-usa.com
To hear presentations from Timothy, Mohamed, Fabrice and many other industry experts, reserve your ticket at http://www.lyophilization-usa.com/prcom
Twitter - @SMIpharm & #lyousa
LinkedIn - SMi Pharma
+44 (0)20 7827 6000
Lyophilization USA Conference| November 15 - 16, 2018 | New Jersey